Posted on 13/07/2010 in Pharmaceutical Company Product News Takeda has won recognition for its social and corporate responsibility initiatives via inclusion in an index compiled by the FTSE Group.
The pharmaceutical company has been listed in the FTSE4Good Global Index of the FTSE4Good Index Series, representing the sixth consecutive year it has been honoured.
Among the good business practices for which Takeda was recognised are its commitment to climate change and environmental measures, upholding of human and labour rights and efforts to counter corporate bribery.
It was one of 663 companies to be included in the latest index, with the list having been compiled from more than 2,400 firms based in 24 different nations.
Responding to the news, Takeda stated that it will "remain committed to the fulfilment of its social responsibility as a global entity, with a view towards realising its mission of striving towards better health for patients worldwide through leading innovation in medicine".
Earlier this month, Takeda announced that its application for marketing approval of the iron deficiency anaemia treatment Feraheme has been accepted by the European Medicines Agency.Other news stories from 13/07/2010
Read more in the Zenopa News Archive
How this news is generated
|
